The German Corporate Governance Code (GCGC) is intended to enhance the trust in the management of listed companies and disclose the rules of corporate governance. Both the Executive Management Board and the Supervisory Board of Heidelberg Pharma AG expressly endorse the Code and have implemented it with exceptions.
The actions of Heidelberg Pharmas' corporate bodies are determined by the principles of good and responsible corporate governance. In this declaration, the Executive Management Board – also acting on behalf of the Supervisory Board – provides its report on corporate governance in the Group pursuant to section 289f of the German Commercial Code (HGB).
On 1 February 2019, the Executive Management Board and the Supervisory Board of Heidelberg Pharma adopted the current declaration of compliance in accordance with Section 161 German Stock Corporation Act. This declaration is valid until the publication of the next declaration of compliance, which is expected at the start of 2020.
Current Articles of Association
The current Articles of Association of Heidelberg Pharma of 16 May 2019 can be found here.